This is due to its involvement in elevating transcription of leukaemia-relevant genes, such as MEIS and HOXA9, which is achieved by its interaction with MLL-fusion oncoproteins and the resultant epigenetic modification of such genes by H3K79 methylation14,35–39. Here, KMT2A is linked to leukemia.